Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Organogenesis Holdings Inc shares valued at $186,866 were sold by Gillheeney Gary S. on Dec 13 ’24. At $3.36 per share, Gillheeney Gary S. sold 55,615 shares. The insider’s holdings dropped to 3,044,779 shares worth approximately $9.87 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Gillheeney Gary S. sold 5,585 shares, netting a total of over 19,492 in proceeds. Following the sale of shares at $3.49 each, the insider now holds 3,039,194 shares.
Before that, Gillheeney Gary S. had sold 157,448 shares from its account. In a trade valued at $573,111, the President and CEO traded Organogenesis Holdings Inc shares for $3.64 each. Upon closing the transaction, the insider’s holdings decreased to 157,448 shares, worth approximately $10.19 million.
As published in their initiating research note from Lake Street on June 28, 2024, Organogenesis Holdings Inc [ORGO] has been a Buy and the price target has been revised to $5. Analysts at Cantor Fitzgerald started covering the stock with ‘”an Overweight”‘ outlook in a report released in early February. As of June 15, 2023, Morgan Stanley has initiated its “an Equal-weight” rating for ORGO. Earlier on May 24, 2023, BTIG Research upgraded its rating. Their new recommendation was “a Buy” for ORGO stock which previously was a “a Neutral”.
Analyzing ORGO Stock Performance
During the last five days, there has been a drop of approximately -11.48%. Over the course of the year, Organogenesis Holdings Inc shares have dropped approximately -20.78%. Shares of the company reached a 52-week high of $4.70 on 01/08/24 and a 52-week low of $2.16 on 04/25/24. A 50-day SMA is recorded $3.44, while a 200-day SMA reached $2.93. Nevertheless, trading volume fell to 1.01 million shares from 0.41 million shares the previous day.
Support And Resistance Levels for Organogenesis Holdings Inc (ORGO)
According to the 24-hour chart, there is a support level at 3.10, which, if violated, would cause prices to drop to 2.95. In the upper region, resistance lies at 3.50. The next price resistance is at 3.75. RSI (Relative Strength Index) is 39.72 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.18, which suggests the price will decrease in the coming days. Percent R is at 96.25%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
